CircDYRK1A Suppresses Gastric Cancer Progression via Sponging miR-331-5p to Regulate GADD45A

Shan Chen1, JingFu Liu1, Zhen Li1

  • 1Department of Blood Transfusion, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, NHC Key Laboratory of Cancer Metabolism, Fuzhou, China.

Insights

Circular RNA DYRK1A (circDYRK1A) is downregulated in gastric cancer (GC) and suppresses tumor progression. It inhibits GC cell proliferation, migration, and invasion via the miR-331-5p/GADD45A pathway, offering potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are implicated in cancer progression.
  • Aberrant circRNA expression is observed in various malignancies, including gastric cancer (GC).

Purpose of the Study:

  • To investigate the role and mechanism of circDYRK1A in gastric cancer progression.
  • To explore circDYRK1A as a potential therapeutic target for GC.

Main Methods:

  • Bioinformatics and qRT-PCR for expression analysis.
  • Sanger sequencing, electrophoresis, and RNase R treatment for structural confirmation.
  • Cellular assays (CCK-8, EDU, Transwell) to assess functional impact.
  • Dual luciferase, RIP, Western blotting, and rescue assays to validate molecular interactions.

Main Results:

  • circDYRK1A was significantly downregulated in GC tissues and cell lines.
  • circDYRK1A inhibited GC cell proliferation, migration, and invasion.
  • circDYRK1A acts as a sponge for miR-331-5p, upregulating GADD45A.

Conclusions:

  • circDYRK1A functions as a tumor suppressor in gastric cancer.
  • The circDYRK1A/miR-331-5p/GADD45A axis represents a novel molecular mechanism in GC progression.
  • circDYRK1A holds potential as a therapeutic target for gastric cancer treatment.

Related Concept Videos

Zinc-Sponge Battery Electrodes that Suppress Dendrites06:58

Zinc-Sponge Battery Electrodes that Suppress Dendrites

The goal of the reported protocols is to create rechargeable zinc-sponge electrodes that suppress dendrites and shape change in zinc batteries, such as nickel–zinc or...
4.8K
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

This protocol describes the value of dual energy CT and PET/CT imaging methods in tumor imaging and efficacy evaluation. This article demonstrates the research methods and results acquired by dual energy CT and PET/CT to evaluate the gene regulation and targeted treatment of gastric cancer peritoneal...
11.5K
Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue06:36

Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue

Here, we present a protocol of elastic staining to identify elastic fibers in pT3N0M0 gastric cancer tissues on formalin-fixed, paraffin-embedded sections. Subsequently, we describe a method to determine whether tumor cells invade beyond the elastic...
7.4K
Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines08:42

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines

The current protocol describes methods to establish patient-derived xenograft (PDX) models and primary cancer cell lines from surgical gastric cancer samples. The methods provide a useful tool for drug development and cancer biology...
10.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Bioluminescent Orthotopic Model of Pancreatic Cancer Progression09:25

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Improved understanding of pancreatic cancer biology is critically needed to enable the development of better therapeutic options to treat pancreatic cancer. To address this need, we demonstrate an orthotopic model of pancreatic cancer that permits non-invasive monitoring of cancer progression using in vivo bioluminescence...
27.5K